Variant report
Variant | esv3446937 |
---|---|
Chromosome Location | chr1:173340081-173348710 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554191060 | chr1:173340084-173340085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12723393 | chr1:173340087-173340088 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs185092159 | chr1:173340124-173340125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11804254 | chr1:173340215-173340216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs140370924 | chr1:173340326-173340327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190734176 | chr1:173340351-173340352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6425219 | chr1:173340416-173340417 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs181920730 | chr1:173340425-173340426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115688924 | chr1:173340458-173340459 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144214267 | chr1:173340478-173340479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186634849 | chr1:173340535-173340536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147760227 | chr1:173340547-173340548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191743528 | chr1:173340549-173340550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373831222 | chr1:173340563-173340564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568142911 | chr1:173340564-173340565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552098545 | chr1:173340571-173340572 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550507386 | chr1:173340589-173340590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2422346 | chr1:173340656-173340657 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs116424879 | chr1:173340721-173340722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2422347 | chr1:173340741-173340742 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs2422348 | chr1:173340780-173340781 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs536754650 | chr1:173340802-173340803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2422349 | chr1:173340809-173340810 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs149850494 | chr1:173340813-173340814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183571866 | chr1:173340902-173340903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541874991 | chr1:173340907-173340908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4382762 | chr1:173340972-173340973 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs575687815 | chr1:173340982-173340983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546153521 | chr1:173340990-173340991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564362302 | chr1:173340991-173340992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528339520 | chr1:173341015-173341016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145835956 | chr1:173341033-173341034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188219164 | chr1:173341048-173341049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374814227 | chr1:173341102-173341103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558849444 | chr1:173341153-173341154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528957022 | chr1:173341185-173341186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs370663733 | chr1:173341205-173341206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568549512 | chr1:173341212-173341213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532758571 | chr1:173341222-173341223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552499310 | chr1:173341225-173341226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190421474 | chr1:173341230-173341231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148977528 | chr1:173341231-173341232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1832847 | chr1:173341415-173341416 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs574121660 | chr1:173341434-173341435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182092522 | chr1:173341436-173341437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553792821 | chr1:173341445-173341446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79139561 | chr1:173341467-173341468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575748817 | chr1:173341478-173341479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546213193 | chr1:173341496-173341497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200336387 | chr1:173341517-173341518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:173330400-173344800 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr1:173330400-173355400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
3 | chr1:173333200-173340400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr1:173339000-173340600 | Enhancers | K562 | blood |
5 | chr1:173340400-173340600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr1:173340400-173340600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr1:173343800-173347000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr1:173344800-173345600 | ZNF genes & repeats | Primary T cells from cord blood | blood |
9 | chr1:173345600-173346800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr1:173345600-173368000 | Weak transcription | Primary T cells from cord blood | blood |
11 | chr1:173346400-173346800 | ZNF genes & repeats | Aorta | Aorta |
12 | chr1:173346800-173363800 | Weak transcription | Aorta | Aorta |
13 | chr1:173347000-173348600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr1:173347200-173375000 | Weak transcription | Spleen | Spleen |
15 | chr1:173348400-173349200 | Enhancers | K562 | blood |
16 | chr1:173348600-173349000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr1:173348600-173389400 | Weak transcription | Right Ventricle | heart |